Pharmacological Targets for Correction of Dyslipidemias. Opportunities and Prospects of Therapeutic Use
- Авторы: Kudinov V.A.1, Zakharova T.S.1, Torkhovskaya T.I.1, Ipatova O.M.1, Archakov A.I.1
-
Учреждения:
- Institute of Biomedical Chemistry (IBMC)
- Выпуск: Том 12, № 2 (2018)
- Страницы: 96-113
- Раздел: Article
- URL: https://journals.rcsi.science/1990-7508/article/view/198143
- DOI: https://doi.org/10.1134/S1990750818020075
- ID: 198143
Цитировать
Аннотация
The review summarizes literature data on existing pharmacological agents and novel drug preparations developed for correction of dyslipidemias and molecular mechanisms of their action. Much attention is paid to analysis of experimental and clinical studies aimed at identification of new pharmacological targets for correction of dyslipidemias and characterization of approaches increasing high density lipoproteins functionality. The implementation of alternative pharmacological agents with new alternative mechanisms of action may improve the effectiveness of traditional treatment in the future.
Об авторах
V. Kudinov
Institute of Biomedical Chemistry (IBMC)
Email: tz-post@list.ru
Россия, ul. Pogodinskaya 10, Moscow, 119121
T. Zakharova
Institute of Biomedical Chemistry (IBMC)
Автор, ответственный за переписку.
Email: tz-post@list.ru
Россия, ul. Pogodinskaya 10, Moscow, 119121
T. Torkhovskaya
Institute of Biomedical Chemistry (IBMC)
Email: tz-post@list.ru
Россия, ul. Pogodinskaya 10, Moscow, 119121
O. Ipatova
Institute of Biomedical Chemistry (IBMC)
Email: tz-post@list.ru
Россия, ul. Pogodinskaya 10, Moscow, 119121
A. Archakov
Institute of Biomedical Chemistry (IBMC)
Email: tz-post@list.ru
Россия, ul. Pogodinskaya 10, Moscow, 119121
Дополнительные файлы
